- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Register
- Orphan products
- Raloxifene hydrochloride
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Raloxifene hydrochloride
| EU orphan designation number: | EU/3/10/730
|
| Active ingredient: | Raloxifene hydrochloride |
| Indication: | Treatment of hereditary haemorrhagic telangiectasia |
| Sponsor: | Consejo Superior de Investigaciones Cientificas (CSIC)
C/ Serrano 142, 28006 Madrid, España |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 14/06/2010 | Orphan designation | EMEA/OD/138/09 | (2010)3900 of 10/06/2010 |
CONTACT
EU links
Directorate General Health & Consumers